WuXi AppTec

wuxiapptec.com · Shanghai, China

WuXi AppTec is a global contract research, development, and manufacturing organization that provides R&D, testing, and manufacturing services across small-molecule drugs, biologics, cell and gene therapies, and medical devices to pharmaceutical, biotech, and medical device companies. It operates an integrated platform spanning discovery, preclinical development, clinical trial support, and commercial-scale manufacturing, generating revenue through fee-for-service and long-term outsourcing contracts. The company enables clients to accelerate drug discovery and development while reducing fixed infrastructure costs.

Revenue
$1B+
Employees
5,001+
Founded
2000
Headquarters
Shanghai, China

WuXi AppTec customers on Arbolus

Total customers 49 45 current · 4 former
Reviews growth 18 new reviews since Jun 2026

Customers who reviewed WuXi AppTec

Seniority of WuXi AppTec customers

The largest group of people who reviewed WuXi AppTec holds Director roles (45%), followed by C-Suite (36%) and Manager (19%).

  • Director 45%
  • C-Suite 36%
  • Manager 19%

Customers sample

Data Leader C-Suite NPS 9 Undecided
Not specified Manager NPS 9 Will renew
Other Analyst Director NPS 9 Undecided

Employer names and spend open in the full report, along with the other 46 customers.

What 49 Arbolus experts think of WuXi AppTec

Overall sentiment: Positive

NPS distribution shows 38.8% Promoters, 36.7% Passives, and 24.5% Detractors, with an NPS score of 14.3 and average NPS of 7.78. Renewal intent is mixed: 38.2% Yes, 5.9% No, and 55.9% Not Sure. Stickiness is high, with 69.4% of customers using WuXi for more than one year. Key feedback themes include unmatched scale and speed, capital efficiency, and significant concerns about geopolitical risk and IP protection.

Everything 49 customers told us about WuXi AppTec.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

12 Net Promoter Score, from 49 scored reviews
  • Promoters 18
  • Passives 19
  • Detractors 12

Praised

  • Unmatched Scale and Speed
  • Capital Efficiency for Startups

Criticised

  • Geopolitical and IP Risk
  • Regulatory and Geopolitical Threats

What WuXi AppTec customers say

Unmatched Scale and Speed

“I would highly recommend WuXi because their ability to turn capital into clinical data is unmatched; you are renting an entire, highly optimized drug development infrastructure that accelerates your path to IND faster than anyone else.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Capital Efficiency for Startups

“I would recommend WuXi to a newly funded biotech startup that needs to hit aggressive clinical milestones quickly and wants to preserve cash by avoiding internal lab build-outs.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Geopolitical and IP Risk

“The biggest gap and risk factor with WuXi is geopolitical exposure and supply chain vulnerability, especially due to US-China trade relations and concerns around IP ring-fencing.”

Other Generalist · Health Care · 1,001 to 5,000 employees · North America

Renewal intent

Plan to renew 38%
  • Will renew 13
  • Undecided 19
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 46% 13 answers
  • Director 29% 14 answers
  • Manager 60% 5 answers
  • Not specified 0% 2 answers
  • 8.5/10 Average score from customers who will renew
  • 7.2/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

Report

Nov 2026 49 + 0

For people who use WuXi AppTec

Do you use WuXi AppTec at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 49 customers of WuXi AppTec have already contributed

Takes a few minutes. Your identity stays anonymous.